This is a valid question. In many societies NAFLD prevalence exceeds 25%. It may be more important to screen for advanced NAFLD and combine screening for 'regular' NAFLD with efforts that aim to identify those with the metabolic syndrome.
Join the conversation today. Login to the EASL Community Portal and connect with colleagues around the world.
Are you keen to learn more about cirrhosis and how to manage critically ill cirrhotic patients? Then apply for this course. The EASL Schools of Hepatology are free to those under 35 and/or still in training.
Simply send us your application before July 24. 30 participants will be selected by the EASL Governing Board and will have the opportunity to attend our Clinical School all expenses paid by EASL!